SCHEMBL4959684

SCHEMBL4959684

CC(C)=CC1C(C(=O)OCC(C)C)C1(C)C

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.69
TSHR P16473 8/20 0.49
CYP1A2 P05177 3/20 0.49
CYP2C19 P33261 3/20 0.49
TDP1 Q9NUW8 3/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ALOX15 P16050 1/20 0.37
TRPV1 Q8NER1 1/20 0.36
ADRA2A P08913 1/20 0.36
CNR1 P21554 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
RAB9A P51151 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL294672 0.87 LMNA (0.51) LMNATSHRCYP1A2CYP2C19TDP1
SCHEMBL3681492 0.86 LMNA (0.51) LMNATSHRCYP1A2CYP2C19TDP1
SCHEMBL3681491 0.86 LMNA (0.51) LMNATSHRCYP1A2CYP2C19TDP1
SCHEMBL1150088 0.83 LMNA (0.46) LMNATSHRCYP1A2CYP2C19TDP1
SCHEMBL1150086 0.83 LMNA (0.46) LMNATSHRCYP1A2CYP2C19TDP1
SCHEMBL1150084 0.83 LMNA (0.46) LMNATSHRCYP1A2CYP2C19TDP1
SCHEMBL295824 0.83 LMNA (0.58) LMNATSHRCYP1A2CYP2C19TDP1
SCHEMBL295825 0.83 LMNA (0.58) LMNATSHRCYP1A2CYP2C19TDP1
SCHEMBL3684631 0.82 LMNA (0.45) LMNATSHRCYP1A2CYP2C19TDP1
SCHEMBL3684630 0.82 LMNA (0.45) LMNATSHRCYP1A2CYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1463706-B1 PROCESS FOR PRODUCTION OF 3,3-DIMETHYL-2-FORMYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVES SUMITOMO CHEMICAL CO (JP) 2008-02-27 EP disclosed
US-7262320-B2 Process for production of 3,3-dimethyl-2-formylcyclopropanecarboxylic acid derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-08-28 US disclosed
US-20050090685-A1 Process for production of 3,3-dimethyl-2-formylcyclopropanecarboxylic acid derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-04-28 US disclosed
EP-1463706-A1 PROCESS FOR PRODUCTION OF 3,3-DIMETHYL-2-FORMYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVES Sumitomo Chemical Company, Limited (JP) 2004-10-06 EP disclosed
WO-2003059861-A1 PROCESS FOR PRODUCTION OF 3,3-DIMETHYL-2-FORMYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-07-24 WO disclosed
US-6011169-A Process for producing optically active cyclopropanecaboxylic acid esters SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-01-04 US disclosed
EP-0891965-A1 Process for producing optically active cyclopropanecarboxylic acid esters SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1999-01-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090685-A1 Process for production of 3,3-dimethyl-2-formylcyclopropanecarboxylic acid derivatives ADSL, CMPK1, MRPL21 LMNA 4209/4885TSHR 3876/4885CYP1A2 264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.